Related Experiment Video
Updated: Apr 19, 2026
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer
Abstract:
Gastric cancer claims many lives around the world, particularly in Asia. Although diagnosis and treatment has improved, long-term survival of patients is still poor and there is an urgent need to develop more effective treatments for this disease. This review outlines some of the more innovative high-throughput screening-based approaches and strategies that may be used to identify compounds that have new or novel mechanisms of action and could be developed further as possible gastric cancer treatments in the future.
Insights
New high-throughput screening methods offer hope for discovering novel gastric cancer treatments. This review explores innovative strategies to identify compounds with unique mechanisms of action for improved patient survival.
Area of Science:
- Oncology
- Pharmacology
- Drug Discovery
Background:
- Gastric cancer remains a significant global health challenge, particularly in Asia, with high mortality rates.
- Despite advancements in diagnosis and treatment, long-term patient survival for gastric cancer is still suboptimal.
- There is a critical need for novel therapeutic strategies to combat gastric cancer effectively.
Purpose of the Study:
- To review innovative high-throughput screening (HTS) approaches for identifying potential gastric cancer therapeutics.
- To highlight strategies for discovering compounds with new or novel mechanisms of action.
- To explore future directions in developing effective treatments for gastric cancer.
Main Methods:
- Review of current literature on high-throughput screening technologies in cancer research.
- Analysis of strategies employed in HTS for drug discovery targeting gastric cancer.
- Identification of innovative screening platforms and methodologies.
Main Results:
- High-throughput screening offers a powerful platform for the rapid identification of bioactive compounds.
- Novel screening strategies can uncover compounds with previously unknown mechanisms of action against gastric cancer cells.
- Integration of HTS with other advanced technologies can accelerate drug development pipelines.
Conclusions:
- Innovative high-throughput screening approaches are crucial for identifying novel gastric cancer drug candidates.
- Discovering compounds with unique mechanisms of action is key to overcoming therapeutic resistance and improving patient outcomes.
- Further research and development in HTS are essential for advancing gastric cancer treatment strategies.
